We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ARLINGTON, Va., Dec. 1 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, The Market Outlook for Research Products in FY2010. The 8.2 billion dollars appropriated to...
ORANGE COUNTY, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate...
By Jon Kamp Of DOW JONES NEWSWIRES The medical-devices sector's trade organization asked Senate Finance Chairman Max Baucus on Monday to drop a proposed $4 billion annual fee for the industry as...
Improves Full Year Earnings Outlook ORANGE COUNTY, Calif., July 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer and marketer of products that...
CHICAGO, March 26 /PRNewswire/ -- "Options News," hosted by Carrie Long and http://www.onn.tv/ Chief Investment Strategist Jud Pyle, reviews futures and overseas trading, discusses the latest...
Johns Hopkins Report Represents Major Step in Cancer Genome Research FULLERTON, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Agencourt Bioscience Corporation, a Beckman Coulter company, announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -0.588235294118 | 17 | 17.05 | 16.7 | 3206 | 16.8 | DE |
4 | 0.05 | 0.296735905044 | 16.85 | 17.2 | 15.7 | 4749 | 16.51398728 | DE |
12 | 1.45 | 9.38511326861 | 15.45 | 18.4 | 15.15 | 9067 | 16.40295184 | DE |
26 | 1.5 | 9.74025974026 | 15.4 | 18.4 | 14.2 | 6233 | 15.94234518 | DE |
52 | -2.9 | -14.6464646465 | 19.8 | 19.8 | 14.2 | 5145 | 16.29797114 | DE |
156 | 3.25 | 23.8095238095 | 13.65 | 19.8 | 10.25 | 3697 | 15.08822173 | DE |
260 | 2.25 | 15.3583617747 | 14.65 | 19.8 | 7.4 | 4922 | 12.97631177 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions